Page 60 - BH-2-4

Brain & Heart Stem cells in cardiovascular disease

26. Liu C, Han D, Liang P, et al. The current dilemma and Maturing differentiated human pluripotent stem
breakthrough of stem cell therapy in ischemic heart disease. cells in vitro: Methods and challenges. Development.
Front Cell Dev Biol. 2021;9:636136. 2023;150(11):dev201103.
doi: 10.3389/fcell.2021.636136 doi: 10.1242/dev.201103
27. Szaraz P, Gratch YS, Iqbal F, Librach CL. In vitro differentiation 31. Lovell-Badge R, Anthony E, Barker RA, et al. ISSCR
of human mesenchymal stem cells into functional Guidelines for stem cell research and clinical translation:
cardiomyocyte-like cells. J Vis Exp. 2017;126:55757. The 2021 update. Stem Cell Reports. 2021;16(6):1398-1408.
doi: 10.3791/55757 doi: 10.1016/j.stemcr.2021.05.012
28. Farahzadi R, Fathi E, Valipour B, Ghaffary S. Stem cells- 32. Rojewski MT, Fekete N, Baila S, et al. GMP-Compliant
derived exosomes as cardiac regenerative agents. Int J isolation and expansion of bone marrow-derived MSCs
Cardiol Heart Vasc. 2024;52:101399. in the closed, automated device quantum cell expansion
system. Cell Transplant. 2013;22(11):1981-2000.
doi: 10.1016/j.ijcha.2024.101399
doi: 10.3727/096368912X657990
29. Afzal J, Liu Y, Du W, et al. Cardiac ultrastructure inspired
matrix induces advanced metabolic and functional 33. Codinach M, Blanco M, Ortega I, et al. Design and validation
maturation of differentiated human cardiomyocytes. Cell of a consistent and reproducible manufacture process for
Rep. 2022;40(4):111146. the production of clinical-grade bone marrow–derived
multipotent mesenchymal stromal cells. Cytotherapy.
doi: 10.1016/j.celrep.2022.111146 2016;18(9):1197-1208.
30. Ottaviani D, ter Huurne M, Elliott DA, Bellin M, Mummery CL. doi: 10.1016/j.jcyt.2016.05.012

Volume 2 Issue 4 (2024) 10 doi: 10.36922/bh.4521